Publication | Open Access

A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity

Gastrointestinal OncologyMedicinePharmacologyColorectal CancerMetastatic Colorectal CancerFirst-line TreatmentPharmacotherapyCancer TreatmentDifferent SchedulesOncologyRadiation Oncology